Focused on Every Breath
Diagnose Asthma with Confidence
Methapharm Respiratory’s ambition is to ensure people with asthma symptoms have the right diagnosis.
Methapharm Respiratory is part of Methapharm Specialty Pharmaceuticals.
Asthma is one of the most prevalent chronic respiratory conditions globally. Ensuring that patients have the right diagnosis is the first step in improving the lives of millions of people who struggle with the disease. We provide clinicians with the diagnostic tools to accurately assess people experiencing symptoms like cough, wheeze and shortness of breath. Our globally trusted diagnostic products are recommended in the ERS/ATS guidelines as well as other international practice guidelines.
Bronchial challenge tests with Provocholine (methacholine) and Aridol (mannitol), along with measuring the level of fractional exhaled nitric oxide (FeNO) in human breath using Vivatmo pro, are objective and evidence-based measures of airway hyperresponsiveness and inflammation. Both are key features of asthma. The right diagnosis is key.
As a committed partner, we also offer training and education (CRCE) at no cost to support clinicians as they help patients along their diagnostic journey.
NOW AVAILABLE!
NOW AVAILABLE!
Consider the consequences of an incorrect diagnosis of asthma:
Ineffective treatments
Inappropriate medications
Poor quality of life
Impact on work and school performance
Consider the consequences of an incorrect diagnosis of asthma:
Ineffective treatments
Inappropriate medications
Poor quality of life
Impact on work and school performance
Blog
May is National Asthma and Allergy Awareness Month
In May, we observe National Asthma and Allergy Awareness Month. Since 1984, the Asthma and Allergy Foundation of America (AAFA) has designated May for raising awareness about these conditions. It’s a peak season for people with asthma and allergies, making it an ideal...
April is Donate Life Month
There are currently 103,000 people in the US awaiting life-saving organ transplants. Since about 46,000 organ transplants were completed in the US in 2023, the need for this life-saving treatment far outstrips the supply of organs for transplant. As a result of the...
Embracing Change: A Look into the 2024 GOLD Guidelines for COPD
Gina Hoots, MSEd, RRT-ACCS, RPFT, CCSH, AE-C, CHC In pulmonary medicine, keeping up with the latest advancements and evidence is crucial for providing optimal care to patients with chronic obstructive pulmonary disease (COPD). The Global Initiative for Chronic...